Skip to search formSkip to main contentSkip to account menu

Respiratory Syncytial Virus Vaccines

Known as: rsv vaccine, RSV Vaccines, Vaccines, RSV 
Vaccines or candidate vaccines used to prevent infection with RESPIRATORY SYNCYTIAL VIRUSES.
National Institutes of Health

Related topics

Related topics

9 relations

Narrower (2)

BBG2Na vaccineMEDI-559
In BloodProcess of secretionagonistsantagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Obstetrical and neonatal case definitions for immunization safety data
Review
2013
Review
2013
Respiratory syncytial virus vaccine development.
2013
2013
Intranasal immunization with W805EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model
Respiratory Syncytial Virus (RSV) is a ubiquitous virus that infects almost all people by age two and is a major source of… 
2013
2013
Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines.
BACKGROUND Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract illness (LRTI) in children. Several… 
Review
2012
Review
2012
The recent progress in RSV vaccine technology.
The most effective way to control RSV infection would be the development of an expedient and safe vaccine. Subunit vaccines, live… 
2003
2003
Priming of multiple T cell subsets by modified-live and inactivated bovine respiratory syncytial virus vaccines.
1999
1999
A simple and reproducible method for collecting nasal secretions in frail elderly adults, for measurement of virus-specific IgA.
The standard method for collection of respiratory secretions, by use of a nasal wash (NW) to measure virus-specific IgA, is… 
Highly Cited
1996
Highly Cited
1996
Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates.
Optimal immunization of neonates against disease caused by respiratory syncytial virus (RSV) probably will require multiple doses… 
1994
1994
Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model.
Highly Cited
1992
Highly Cited
1992
Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee.
Recombinant adenovirus type 4, 5, and 7 expressing the fusion glycoprotein (F) gene, the attachment glycoprotein (G) gene, or… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)